3oa9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:3oa9.jpg|left|200px]]
 
- 
-
<!--
 
-
The line below this paragraph, containing "STRUCTURE_3oa9", creates the "Structure Box" on the page.
 
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
 
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
 
-
or leave the SCENE parameter empty for the default display.
 
-
-->
 
{{STRUCTURE_3oa9| PDB=3oa9 | SCENE= }}
{{STRUCTURE_3oa9| PDB=3oa9 | SCENE= }}
- 
===Effector domain of influenza A/Duck/Albany/76 NS1===
===Effector domain of influenza A/Duck/Albany/76 NS1===
 +
{{ABSTRACT_PUBMED_21464929}}
-
 
+
==Function==
-
<!--
+
[[http://www.uniprot.org/uniprot/NS1_I76A2 NS1_I76A2]] Inhibits post-transcriptional processing of cellular pre-mRNA, by binding and inhibiting two cellular proteins that are required for the 3'-end processing of cellular pre-mRNAs: the 30 kDa cleavage and polyadenylation specificity factor (CPSF4) and the poly(A)-binding protein 2 (PABPN1). This results in the accumulation of unprocessed 3' end pre-mRNAs which can't be exported from the nucleus. Cellular protein synthesis is thereby shut off very early after virus infection. Viral protein synthesis is not affected by the inhibition of the cellular 3' end processing machinery because the poly(A) tails of viral mRNAs are produced by the viral polymerase through a stuttering mechanism (By similarity). Prevents the establishment of the cellular antiviral state by inhibiting TRIM25-mediated DDX58 ubiquitination, which normally triggers the antiviral transduction signal that leads to the activation of type I IFN genes by transcription factors like IRF3 and IRF7. Prevents human EIF2AK2/PKR activation, either by binding double-strand RNA, or by interacting directly with EIF2AK2/PKR. This function may be important at the very beginning of the infection, when NS1 is mainly present in the cytoplasm. Also binds poly(A) and U6 snRNA. Suppresses the RNA silencing-based antiviral response in Drosophila cells (By similarity).
-
The line below this paragraph, {{ABSTRACT_PUBMED_21464929}}, adds the Publication Abstract to the page
+
-
(as it appears on PubMed at http://www.pubmed.gov), where 21464929 is the PubMed ID number.
+
-
-->
+
-
{{ABSTRACT_PUBMED_21464929}}
+
==About this Structure==
==About this Structure==
Line 22: Line 10:
==Reference==
==Reference==
-
<ref group="xtra">PMID:021464929</ref><references group="xtra"/>
+
<ref group="xtra">PMID:021464929</ref><references group="xtra"/><references/>
[[Category: Influenza a virus]]
[[Category: Influenza a virus]]
[[Category: Hale, B G.]]
[[Category: Hale, B G.]]
Line 31: Line 19:
[[Category: Russell, R J.M.]]
[[Category: Russell, R J.M.]]
[[Category: Taylor, M A.]]
[[Category: Taylor, M A.]]
 +
[[Category: Viral protein]]

Revision as of 11:55, 24 April 2013

Template:STRUCTURE 3oa9

Contents

Effector domain of influenza A/Duck/Albany/76 NS1

Template:ABSTRACT PUBMED 21464929

Function

[NS1_I76A2] Inhibits post-transcriptional processing of cellular pre-mRNA, by binding and inhibiting two cellular proteins that are required for the 3'-end processing of cellular pre-mRNAs: the 30 kDa cleavage and polyadenylation specificity factor (CPSF4) and the poly(A)-binding protein 2 (PABPN1). This results in the accumulation of unprocessed 3' end pre-mRNAs which can't be exported from the nucleus. Cellular protein synthesis is thereby shut off very early after virus infection. Viral protein synthesis is not affected by the inhibition of the cellular 3' end processing machinery because the poly(A) tails of viral mRNAs are produced by the viral polymerase through a stuttering mechanism (By similarity). Prevents the establishment of the cellular antiviral state by inhibiting TRIM25-mediated DDX58 ubiquitination, which normally triggers the antiviral transduction signal that leads to the activation of type I IFN genes by transcription factors like IRF3 and IRF7. Prevents human EIF2AK2/PKR activation, either by binding double-strand RNA, or by interacting directly with EIF2AK2/PKR. This function may be important at the very beginning of the infection, when NS1 is mainly present in the cytoplasm. Also binds poly(A) and U6 snRNA. Suppresses the RNA silencing-based antiviral response in Drosophila cells (By similarity).

About this Structure

3oa9 is a 2 chain structure with sequence from Influenza a virus. Full crystallographic information is available from OCA.

Reference

  • Kerry PS, Ayllon J, Taylor MA, Hass C, Lewis A, Garcia-Sastre A, Randall RE, Hale BG, Russell RJ. A Transient Homotypic Interaction Model for the Influenza A Virus NS1 Protein Effector Domain. PLoS One. 2011 Mar 28;6(3):e17946. PMID:21464929 doi:10.1371/journal.pone.0017946

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools